[EN] HETEROARYL-SUBSTITUTED TRIAZOLES AS APJ RECEPTOR AGONISTS<br/>[FR] TRIAZOLES SUBSTITUÉS PAR HÉTÉROARYLE UTILISÉS EN TANT QU'AGONISTES DU RÉCEPTEUR APJ
申请人:AMGEN INC
公开号:WO2018097945A1
公开(公告)日:2018-05-31
Compounds of Formula (I) and Formula (II), pharmaceutically acceptable salt thereof, stereoisomers of any of the foregoing, or mixtures thereof are agonists of the APJ Receptor and may have use in treating cardiovascular and other conditions. Compounds of Formula I and Formula II have the following structures: where the definitions of the variables are provided herein.
Agonists of the apelin receptor and methods of use thereof
申请人:Sanford Burnham Prebys Medical Discovery Institute
公开号:US10570128B2
公开(公告)日:2020-02-25
Provided herein are small molecule agonists of the apelin receptor for the treatment of disease. The compounds disclosed herein are useful for the treatment of a range of cardiovascular, renal and metabolic conditions. The present invention is based on the seminal discovery of a series of potent small molecule agonists of the apelin receptor, which are useful for the treatment of diseases including heart failure, chronic kidney disease, hypertension, and metabolic disorders such as insulin resistance/diabetes and obesity. The compounds disclosed herein are highly specific for the apelin receptor versus the angiotensin II receptor (ATI).
本文提供了用于治疗疾病的阿佩林受体小分子激动剂。本文公开的化合物可用于治疗一系列心血管、肾脏和代谢疾病。本发明基于一系列凋亡素受体强效小分子激动剂的开创性发现,这些激动剂可用于治疗包括心力衰竭、慢性肾病、高血压以及胰岛素抵抗/糖尿病和肥胖症等代谢性疾病。与血管紧张素 II 受体(ATI)相比,本文公开的化合物对阿佩林受体具有高度特异性。
Heteroaryl-substituted triazoles as APJ receptor agonists
申请人:AMGEN INC.
公开号:US11046680B1
公开(公告)日:2021-06-29
Compounds of Formula (I) and Formula (II), pharmaceutically acceptable salt thereof, stereoisomers of any of the foregoing, or mixtures thereof are agonists of the APJ Receptor and may have use in treating cardiovascular and other conditions. Compounds of Formula I and Formula II have the following structures: where the definitions of the variables are provided herein.
式(I)和式(II)化合物、其药学上可接受的盐、前述任何化合物的立体异构体或其混合物是 APJ 受体的激动剂,可用于治疗心血管疾病和其他疾病。式 I 和式 II 的化合物具有如下结构: 其中变量的定义在本文中提供。
Iron-CatalyzedN-Arylations of Amides
作者:Arkaitz Correa、Simon Elmore、Carsten Bolm
DOI:10.1002/chem.200800293
日期:2008.4.18
HETEROARYL-SUBSTITUTED TRIAZOLES AS APJ RECEPTOR AGONISTS